Impact of a clinical pathway on treatment outcome in patients with acute pancreatitis

被引:8
|
作者
Vujasinovic, Miroslav [1 ]
Makuc, Jana [1 ]
Tepes, Bojan [2 ]
Marolt, Apolon [1 ]
Kikec, Zdenko [1 ]
Robac, Nace [1 ]
机构
[1] Gen Hosp Slovenj Gradec, Dept Internal Med, Slovenj Gradec 2380, Slovenia
[2] Abakus Med Diagnost Ctr Rogaska, Rogashka Slatina 3250, Slovenia
关键词
Acute; Pancreatitis; Treatment; Clinical pathway; Indicator; Quality; CARBOHYDRATE-DEFICIENT TRANSFERRIN; GAMMA-GLUTAMYL-TRANSFERASE; CHRONIC ALCOHOL-ABUSE; RECOVERY; CONSUMPTION; POPULATION; GUIDELINES; SEVERITY; BILIARY; TOBACCO;
D O I
10.3748/wjg.v21.i30.9150
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To determine the impact of a clinical pathway (CP) on acute pancreatitis (AP) treatment outcome. METHODS: A retrospective analysis of medical records was performed. We compared the results of AP treatment outcome over two time periods in our centre, before (2006-2007) and after (2010-2012) the implementation of a CP. The CP comprised the following indicators of quality: performance of all laboratory tests on admission (including lipids and carbohydrate deficient transferrin), determination of AP aetiology, abdomen ultrasound (US) within the first 24 h after admission, contrast-enhanced computed tomography of the abdomen in all cases of suspected pancreatic necrosis, appropriately selected and sufficiently used antibiotic therapy (if necessary), pain control, adequate hydration, control of haemodynamic parameters and transfer to the Intensive Care Unit (ICU) (if necessary), endoscopic retrograde cholangiopancreatography (ERCP) in biliary AP, surgical treatment (if necessary), and advice on outpatient follow-up after discharge. A comparison of the length of stay with that in other Slovenian hospitals was also performed. RESULTS: There were 139 patients treated in the three-year period after the introduction of a CP, of which 81 (58.3%) were male and 58 (41.7%) female. The patients' mean age was 59.6 similar to 17.3 years. The most common aetiologies were alcoholism and gallstones (38.8% each), followed by unexplained (11.5%), drug-induced, hypertriglyceridemia, post ERCP (2.9% each) and tumours (2.2%). Antibiotic therapy was prescribed in 72 (51.8%) patients. Abdominal US was performed in all patients within the first 24 h after admission. Thirty-two (23.0%) patients were treated in the ICU. Four patients died (2.9%). In comparison to 2006-2007, we found an increased number of alcoholic and biliary AP and an associated decrease in the number of unexplained aetiology cases. The use of antibiotics also significantly decreased after the implementation of a CP (from 70.3% to 51.8%; P = 0.003). There was no statistically significant difference in mortality (1.8% vs 2.9%). The length of stay was significantly shorter when compared to the Slovenian average (P = 0.018). CONCLUSION: The introduction of a CP has improved the treatment of patients with AP, as assessed by all of the observed parameters.
引用
收藏
页码:9150 / 9155
页数:6
相关论文
共 50 条
  • [1] Impact of a clinical pathway on treatment outcome in patients with acute pancreatitis
    Miroslav Vujasinovic
    Jana Makuc
    Bojan Tepes
    Apolon Marolt
    Zdenko Kikec
    Nace Robac
    [J]. World Journal of Gastroenterology, 2015, (30) : 9150 - 9155
  • [2] The Clinical Characteristics and Outcome of Elderly Patients With Acute Pancreatitis
    Wang, Qiu
    Chen, Yiqiu
    Huang, Ping
    Su, De
    Gao, Fei
    Fu, Xiaoyun
    Fu, Bao
    [J]. PANCREAS, 2022, 51 (10) : 1284 - 1291
  • [3] The Impact of Diabetes Mellitus on Clinical Outcome of Acute Pancreatitis in Japan
    Kikuta, K.
    Masamune, A.
    Hamada, S.
    Shimosegawa, T.
    [J]. PANCREAS, 2014, 43 (08) : 1377 - 1377
  • [4] Impact of the Anatomical Location of Necrosis on Outcome in Patients of Acute Pancreatitis
    Dhaka, N.
    Munit, A.
    Samanta, J.
    Prasada, R.
    Gupta, P.
    Gupta, V.
    Yadav, T. D.
    Sinha, S. K.
    Kochhar, R.
    [J]. PANCREAS, 2015, 44 (08) : 1369 - 1370
  • [5] Impact of a care pathway in acute pancreatitis
    McCallum, Iain J. D.
    Hicks, Gareth J.
    Attwood, Stephen
    Seymour, Keith
    [J]. FRONTLINE GASTROENTEROLOGY, 2011, 2 (01) : 32 - 34
  • [6] Impact of a care pathway in acute pancreatitis
    McCallum, Iain J. D.
    Hicks, Gareth J.
    Attwood, Stephen
    Seymour, Keith
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2011, 87 (1027) : 379 - 381
  • [7] Cumulative Acute Pancreatitis Outcome Score for Clinical Trials in Acute Pancreatitis
    Huang, W.
    Szatmary, P.
    Iglesia-Garcia, D.
    Sud, A.
    Lane, B.
    Nunes, Q.
    Mukherjee, R.
    Greenhalf, W.
    Raraty, M.
    Sutton, R.
    [J]. PANCREAS, 2015, 44 (08) : 1380 - 1380
  • [8] Clinical characteristics, treatment and outcome of pembrolizumab-induced acute pancreatitis
    Luo, Panpan
    Guo, Yuge
    He, Yang
    Wang, Chunjiang
    [J]. INVESTIGATIONAL NEW DRUGS, 2024, 42 (04) : 369 - 375
  • [9] Comparison of Clinical Course and Outcome of Acute Pancreatitis, Recurrent Acute Pancreatitis and Acute on Chronic Pancreatitis
    Samanta, J.
    Sharma, D. J.
    Dhaka, N.
    Gupta, V.
    Gulati, A.
    Sinha, S. K.
    Kochhar, R.
    [J]. PANCREAS, 2016, 45 (10) : 1536 - 1536
  • [10] Impact of a clinical pathway and standardization of treatment for acute appendicitis
    Takegami, K
    Kawaguchi, Y
    Nakayama, H
    Kubota, Y
    Nagawa, H
    [J]. SURGERY TODAY, 2003, 33 (05) : 336 - 341